Clinical Trials Logo
  1. Home
  2. Esophageal and Gastric Varices
  3. NCT02945930

Study the Safety and Efficacy of "Compont Medical Glue" in the Treatment of Esophagogastric Varices

Esophageal and Gastric Varices Clinical Trial

Official title:
A Prospective Multicenter, Open Study on the Safety and Efficacy of "Compont Medical Glue" in the Treatment of Esophagogastric Varices

Clinical Trial Summary

To observe the Safety and Efficacy of Compont Medical Glue in the Treatment of Esophagogastric Varices.

Clinical Trial Description

"Compont Medical Glue" is a kind of histoacryl producted by Compont Company. It has been used to treat esophagogastric varices for several years. This study is a prospective multicenter,open study on the safety and efficacy of Compont Medical Glue in the treatment of esophagogastric varices. Weather the patient receiving injection of Compont Medical Glue is according to the degree of esophageal-gastric varices and is decided by the experienced endoscopic physicians. No additional intervention will be given to the patients, no matter whether patients are participated in the study. ;

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02945930
Study type Observational
Source Shanghai Zhongshan Hospital
Contact Shiyao Chen, Professor
Phone 86-13601767310
Email chen.shiyao@zs-hospital.sh.cn
Status Recruiting
Phase N/A
Start date September 2016
Completion date November 2018
View Details
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05055713 - A Randomized Controlled Study on the Treatment of Cirrhosis Combined With Hypersplenism N/A
Completed NCT04823780 - The Effects of Early Enteral Nutrition on Endoscopic Therapy of Esophagogastric Varices in Liver Cirrhosis
Completed NCT03244332 - HEMOCC Study. Hemostasis in Cirrhotic Children. N/A
Completed NCT02991612 - Rifaximin in Patients With Gastroesophageal Variceal Bleeding N/A
Recruiting NCT02964195 - Efficacy of Rifaximin in Treatment of Cirrhotic Gastroesophageal Variceal Bleeding N/A
Completed NCT00004641 - A Study to Prevent Complications of High Blood Pressure Caused by Hepatitis in Patients With Cirrhosis Phase 2
Completed NCT02593799 - Non-invasive Prediction of Esophageal Varices in Liver Cirrhosis: A Multicenter Observational Study
Recruiting NCT02719119 - Trial of Monthly Versus Bi-weekly Endoscopic Variceal Ligation for the Prevention of Esophageal Variceal Rebleeding N/A
Recruiting NCT02385422 - The Effect of Carvedilol Vs Propranolol in Cirrhotic Patients With Variceal Bleeding Phase 4
Completed NCT00838864 - Comparison of 3 Days and 7 Days Intravenous Ceftriaxone Prophylaxis for Variceal Bleeding Phase 4
Not yet recruiting NCT03130127 - Continuous Versus Bolus Infusion of Terlipressin for Portal Hypertension Related Bleeding in Liver Cirrhosis N/A
Active, not recruiting NCT05979935 - Prediction of Esophageal Varices in Liver Cirrhosis Using Tongue Bioinformatics
Recruiting NCT02504723 - Carvedilol as an Adjunct to Endoscopic Cyanoacrylate Injection for Secondary Prophylaxis of Gastric Variceal Bleeding Phase 4
Withdrawn NCT00475592 - Validation of Esophageal Variceal Grading: A Comparative Study of Upper Gastrointestinal (GI) Endoscopy and Capsule Endoscopy N/A
Completed NCT05331768 - Comparison of Endoscopic Band Ligation Plus 24-hour Versus 72-hour Terlipressin Therapy N/A
Completed NCT04210297 - Development and Validation of an Noninvasive Model for Predicting High Risk Esophageal Varices in Cirrhosis
Recruiting NCT02311608 - Effects of Terlipressin When Usual Somatostatin or Octreotide Dose Fails N/A
Completed NCT04976543 - Safety of Anticoagulant Therapy After Endoscopic Treatment Phase 4
Not yet recruiting NCT05978752 - Clinical Study on Endoscopic Management of GOV1 Esophagogastric Varices N/A
Recruiting NCT02695732 - The Effect of Carvedilol VS Endoscopic Therapy in Primary Prophylaxis of High-risk Esophageal Gastric Variceal Bleeding Phase 4